The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer

NCT02380196 · clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Abramson Cancer Center at Penn Medicine